Effect of oral consumption of probiotic Lactobacillus planatarum P-8 on fecal microbiota, SIgA, SCFAs, and TBAs of adults of different ages

Nutrition

Volumn 30, Issue 7-8, 2014, Pages 776-783.e1

  Wang, Lifeng ^a   Zhang, Jiachao ^a   Guo, Zhuang ^a   Kwok, Laiyu ^a   Ma, Chen ^a   Zhang, Wenyi ^a   Lv, Qiang ^a   Huang, Weiqiang ^a   Zhang, Heping ^a  

^a INNER MONGOLIA AGRICULTURAL UNIVERSITY   (China)

Author keywords

Fecal microbiota; Gut microbiota; Human; Lactobacillus plantarum; Lp 8; Probiotics

Indexed keywords

BILE ACID; PROBIOTIC AGENT; SECRETORY IMMUNOGLOBULIN; SHORT CHAIN FATTY ACID; IMMUNOGLOBULIN A; VOLATILE FATTY ACID;

ACINETOBACTER; ADULT; AGE; AGED; ARTICLE; ATOPOBIUM; BACTERIAL COUNT; BIFIDOBACTERIUM; DENATURING GRADIENT GEL ELECTROPHORESIS; DESULFOVIBRIO; DIETARY INTAKE; DRUG EFFECT; ENZYME LINKED IMMUNOSORBENT ASSAY; EUBACTERIUM; FECES ANALYSIS; FECES MICROFLORA; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN EXPERIMENT; INTESTINE FLORA; LACTOBACILLUS PLANTARUM; MALE; MICROBIAL DIVERSITY; MICROORGANISM DETECTION; MIDDLE AGED; NORMAL HUMAN; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PSEUDOMONAS; TREATMENT DURATION; VERY ELDERLY; CHEMISTRY; CLINICAL TRIAL; COLON; FECES; GROWTH, DEVELOPMENT AND AGING; LACTOBACILLUS; METABOLISM; MICROBIOLOGY; MICROFLORA;

ADULT; AGED; AGED, 80 AND OVER; BIFIDOBACTERIUM; BILE ACIDS AND SALTS; COLON; DESULFOVIBRIO; FATTY ACIDS, VOLATILE; FECES; HUMANS; IMMUNOGLOBULIN A; LACTOBACILLUS; MICROBIOTA; MIDDLE AGED; PROBIOTICS;

EID: 84903381731     PISSN: 08999007     EISSN: 18731244     Source Type: Journal    
DOI: 10.1016/j.nut.2013.11.018     Document Type: Article

References (33)

1. Arumugam M., Raes J., Pelletier E., Le Paslier D., Yamada T., Mende D.R., et al. Enterotypes of the human gut microbiome. Nature 2011, 473:174-180.
2. Arora T., Singh S., Sharma R.K. Probiotics: interaction with gut microbiome and antiobesity potential. Nutrition 2013, 29:591-596.
3. Palaria A., Johnson-Kanda I., O'Sullivan D.J. Effect of a synbiotic yogurt on levels of fecal bifidobacteria, clostridia, and enterobacteria. Appl Environ Microbiol 2012, 78:933-940.
4. Macfarlane G.T., Macfarlane S. Bacteria, colonic fermentation, and gastrointestinal health. J Aoac Int 2012, 95:50-60.
5. Macia L., Thorburn A.N., Binge L.C., Marino E., Rogers K.E., Maslowski K.M., et al. Microbial influences on epithelial integrity and immune function as a basis for inflammatory diseases. Immunol Rev 2012, 245:164-176.
6. Roy M.J., Dionne S., Marx G., Qureshi I., Sarma D., Levy E., et al. Invitro studies on the inhibition of colon cancer by butyrate and carnitine. Nutrition 2009, 25:1193-1201.
7. Fukuda S., Toh H., Hase K., Oshima K., Nakanishi Y., Yoshimura K., et al. Bifidobacteria can protect from enteropathogenic infection through production of acetate. Nature 2011, 469:543-547.
8. Brandtzaeg P. Role of secretory antibodies in the defence against infections. Int J Med Microbiol 2003, 293:3-15.
9. Cebra J.J. Influences of microbiota on intestinal immune system development. Am J Clin Nutr 1999, 69:1046S-1051S.
10. Kabeerdoss J., Devi R.S., Mary R.R., Prabhavathi D., Vidya R., Mechenro J., et al. Effect of yoghurt containing Bifidobacterium lactis Bb12(R) on faecal excretion of secretory immunoglobulin A and human beta-defensin 2 in healthy adult volunteers. Nutrition 2011, 10:138.
11. Zampa A., Silvi S., Fabiani R., Morozzi G., Orpianesi C., Cresci A. Effects of different digestible carbohydrates on bile acid metabolism and SCFA production by human gut micro-flora grown in an invitro semi-continuous culture. Anaerobe 2004, 10:19-26.
12. Kumar M., Rakesh S., Nagpal R., Hemalatha R., Ramakrishna A., Sudarshan V., et al. Probiotic Lactobacillus rhamnosus GG and aloe vera gel improve lipid profiles in hypercholesterolemic rats. Nutrition 2013, 29:574-579.
13. Iannitti T., Palmieri B. Therapeutical use of probiotic formulations in clinical practice. Clin Nutr 2010, 29:701-725.
14. de Vries M.C., Vaughan E.E., Kleerebezem M., de Vos W.M. Lactobacillus plantarum- survival, functional and potential probiotic properties in the human intestinal tract. Int Dairy J 2006, 16:1018-1028.
15. Bao Y., Zhang Y., Li H., Liu Y., Wang S., Dong X., et al. Invitro screen of Lactobacillus plantarum as probiotic bacteria and their fermented characteristics in soymilk. Ann Microbiol 2012, 62:1311-1320.
16. Ahmed M., Prasad J., Gill H., Stevenson L., Gopal P. Impact of consumption of different levels of Bifidobacterium lactis HN019 on the intestinal microflora of elderly human subjects. J Nutr Health Aging 2007, 11:26-31.
17. Gong H.Q., Ramalingam N., Chen L.Q., Che J., Wang Q.H., Wang Y.M., et al. Microfluidic handling of PCR solution and DNA amplification on a reaction chamber array biochip. Biomed Microdevices 2006, 8:167-176.
18. Madi A., Alnabhani Z., Leneveu C., Mijouin L., Feuilloley M., Connil N. Pseudomonas fluorescens can induce and divert the human beta-defensin-2 secretion in intestinal epithelial cells to enhance its virulence. Arch Microbiol 2013, 195:189-195.
19. Roy S., Viswanathan R., Singh A., Das P., Basu S. Gut colonization by multidrug-resistant and carbapenem-resistant Acinetobacter baumannii in neonates. Eur J Clin Microbiol 2010, 29:1495-1500.
20. Duncan S.H., Flint H.J. Proposal of a neotype strain (A1-86) for Eubacterium rectale. Request for an opinion. Int J Syst Evol Micr 2008, 58:1735-1736.
21. Hansen R., Russell R.K., Reiff C., Louis P., McIntosh F., Berry S.H., et al. Microbiota of de-novo pediatric IBD: increased Faecalibacterium prausnitzii and reduced bacterial diversity in Crohn's but not in ulcerative colitis. Am J Gastroenterol 2012, 107:1913-1922.
22. Rowan F.E., Docherty N.G., Coffey J.C., O'Connell P.R. Sulphate-reducing bacteria and hydrogen sulphide in the aetiology of ulcerative colitis. Brit J Surg 2009, 96:151-158.
23. Bao Y., Wang Z.L., Zhang Y., Zhang J.C., Wang L.F., Dong X.M., et al. Effect of Lactobacillus plantarum P-8 on lipid metabolism in hyperlipidemic rat model. Eur J Lipid Sci Tech 2012, 114:1230-1236.
24. McLachlan A.J., Pont L.G. Drug metabolism in older people-a key consideration in achieving optimal outcomes with medicines. J Gerontol a-Biol 2012, 67:175-180.
25. Rampelli S., Candela M., Severgnini M., Biagi E., Turroni S., Roselli M., et al. A probiotics-containing biscuit modulates the intestinal microbiota in the elderly. J Nutr Health Aging 2013, 17:166-172.
26. Takaishi H., Matsuki T., Nakazawa A., Takada T., Kado S., Asahara T., et al. Imbalance in intestinal microflora constitution could be involved in the pathogenesis of inflammatory bowel disease. Int J Med Microbiol 2008, 298:463-472.
27. Lahtinen S.J., Forssten S., Aakko J., Granlund L., Rautonen N., Salminen S., et al. Probiotic cheese containing Lactobacillus rhamnosus HN001 and Lactobacillus acidophilus NCFM(R) modifies subpopulations of fecal lactobacilli and Clostridium difficile in the elderly. Age (Dordr) 2012, 34:133-143.
28. Kabeerdoss J., Devi R.S., Mary R.R., Prabhavathi D., Vidya R., Mechenro J., et al. Effect of yoghurt containing Bifidobacterium lactis Bb12 (R) on faecal excretion of secretory immunoglobulin A and human beta-defensin 2 in healthy adult volunteers. Nutrition 2011, 10:138.
29. Bjorklund M., Ouwehand A.C., Forssten S.D., Nikkila J., Tiihonen K., Rautonen N., et al. Gut microbiota of healthy elderly NSAID users is selectively modified with the administration of Lactobacillus acidophilus NCFM and lactitol. Age 2012, 34:987-999.
30. Ouwehand A.C., Tiihonen K., Saarinen M., Putaala H., Rautonen N. Influence of a combination of Lactobacillus acidophilus NCFM and lactitol on healthy elderly: intestinal and immune parameters. Brit J Nutr 2009, 101:367-375.
31. Louis P., Scott K.P., Duncan S.H., Flint H.J. Understanding the effects of diet on bacterial metabolism in the large intestine. J Appl Microbiol 2007, 102:1197-1208.
32. De Preter V., Hamer H.M., Windey K., Verbeke K. The impact of pre- and/or probiotics on human colonic metabolism: does it affect human health?. Mol Nutr Food Res 2011, 55:46-57.
33. Tannock etal. 1989.